Parabilis Medicines, Inc. carries a market capitalization of 3.09B, placing it among publicly traded companies globally.
| Market Cap | 3.09B |
| Enterprise Value | N/A |
Parabilis Medicines, Inc.'s stock has gained approximately 26.75% over the past 52 weeks. The 50-day moving average sits at 34.89, while the 200-day moving average is 32.73.
| Beta (5Y) | N/A |
| 52-Week Price Change | 26.75% |
| 50-Day Moving Average | 34.89 |
| 200-Day Moving Average | 32.73 |
| Average Volume (20 Days) | N/A |